VAPOR-C : Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial

Male or<br/>FemaleGender Male or
Female

RecruitingStatus Recruiting

Surgical<br/>TrialTypeSurgical
Trial

ThreePhase Three

18+Age Over 18

Advanced CancersCancer LocationMulti-Cancer
Trial

Surgical,Treatment | Bowel (colorectum),LungColon,Colorectum,Lung,Non-Small Cell Lung Cancer,Rectum

Trial Overview Read MoreRead more

This study aims to understand the impact of anaesthesia on duration of disease free survival in patients undergoing surgery for colorectal or non-small cell lung cancer.
 

This trial is treating patients with colorectal cancer or non-small cell lung cancer.

This is a surgical trial.

You may be able to join this trial if:

  • Your cancer has not spread to other parts of the body.

You may be excluded from this trial if:

  • You have a certain disease or psychological condition.
  • You have been diagnosed with a prior or secondary type of cancer.
  • You have had certain treatments, surgical procedures or drugs.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial

Other Non-Commercial Sponsor

Peter MacCallum Cancer Centre

Summary

This trial is testing the superiority of propofol (total intravenous anaesthesia -TIVA) over sevoflurane (inhalational volatile anaesthesia) and intravenous lidocaine over placebo in patients undergoing surgery for colorectal or non small cell lung cancer (NSCLC). Eligible participants will be randomly allocated to one of four treatment arms.

Recruiting Hospitals Read MoreRead more

Peter MacCallum Cancer Centre, Surgery
Parkville
Ms Tina Thorpe
tina.thorpe@petermac.org
03 9656 1521

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.

Next